Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prospects for cannabinoid therapies in basal ganglia disorders.
Br J Pharmacol. 2011 Aug;163(7):1365-78. doi: 10.1111/j.1476-5381.2011.01365.x.
Br J Pharmacol. 2011.
PMID: 21545415
Free PMC article.
Review.
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
de Lago E, Moreno-Martet M, Cabranes A, Ramos JA, Fernández-Ruiz J.
de Lago E, et al. Among authors: moreno martet m.
Neuropharmacology. 2012 Jun;62(7):2299-308. doi: 10.1016/j.neuropharm.2012.01.030. Epub 2012 Feb 8.
Neuropharmacology. 2012.
PMID: 22342378
Item in Clipboard
A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
Feliú A, Moreno-Martet M, Mecha M, Carrillo-Salinas FJ, de Lago E, Fernández-Ruiz J, Guaza C.
Feliú A, et al. Among authors: moreno martet m.
Br J Pharmacol. 2015 Jul;172(14):3579-95. doi: 10.1111/bph.13159. Epub 2015 May 20.
Br J Pharmacol. 2015.
PMID: 25857324
Free PMC article.
Item in Clipboard
Cannabinoids, multiple sclerosis and neuroprotection.
de Lago E, Gómez-Ruiz M, Moreno-Martet M, Fernández-Ruiz J.
de Lago E, et al. Among authors: moreno martet m.
Expert Rev Clin Pharmacol. 2009 Nov;2(6):645-60. doi: 10.1586/ecp.09.42.
Expert Rev Clin Pharmacol. 2009.
PMID: 22112258
Item in Clipboard
Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases.
Moreno-Martet M, Mestre L, Loría F, Guaza C, Fernández-Ruiz J, de Lago E.
Moreno-Martet M, et al.
Neurosci Lett. 2012 Feb 6;508(2):67-72. doi: 10.1016/j.neulet.2011.12.020. Epub 2011 Dec 22.
Neurosci Lett. 2012.
PMID: 22206832
Item in Clipboard
Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
Moreno-Martet M, Espejo-Porras F, Fernández-Ruiz J, de Lago E.
Moreno-Martet M, et al.
CNS Neurosci Ther. 2014 Sep;20(9):809-15. doi: 10.1111/cns.12262. Epub 2014 Apr 7.
CNS Neurosci Ther. 2014.
PMID: 24703394
Free PMC article.
Item in Clipboard
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Moreno-Martet M, Feliú A, Espejo-Porras F, Mecha M, Carrillo-Salinas FJ, Fernández-Ruiz J, Guaza C, de Lago E.
Moreno-Martet M, et al.
Mult Scler Relat Disord. 2015 Nov;4(6):505-11. doi: 10.1016/j.msard.2015.08.001. Epub 2015 Aug 5.
Mult Scler Relat Disord. 2015.
PMID: 26590655
Item in Clipboard
Cite
Cite